Literature DB >> 372483

Bactericidal activity of the alternative complement pathway generated from 11 isolated plasma proteins.

R D Schreiber, D C Morrison, E R Podack, H J Müller-Eberhard.   

Abstract

Exposure of E. coli K12 W1485 to the cytolytic alternative pathway assembled from the 11 isolated pathway proteins resulted in killing of the bacteria, as evidenced by loss of viability. Lysis of the bacteria required introduction of lysozyme into the reaction mixture. The time-course and dose dependency of bacteriolysis in the isolated system were identical to those in C4-depleted serum. The bacteriolytic activity of the pathway was highly dependent on the concentration of the pathway proteins and became insignificant at 1:16 physiological concentration. Electron microscopic visualization of killed and of lysed bacteria revealed numerous complement membrane lesions and partial disintegration of the outer phospholipid membrane. Scanning electron microscopy showed that killed bacteria were enlarged, partially collapsed and exhibited irregular surface protrusions. Lysed bacteria were fragmented and appeared polymorphic. This study demonstrates that the alternative pathway, in absence of immunoglobulins, has the potential or eradicating gram-negative bacteria.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 372483      PMCID: PMC2184846          DOI: 10.1084/jem.149.4.870

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  25 in total

1.  Development of bactericidal properties against gram-negative organisms in the serum of young animals.

Authors:  J STERZL; J KOSTKA; A LANC
Journal:  Folia Microbiol (Praha)       Date:  1962-05       Impact factor: 2.099

2.  The bactericidal action of normal serum and the properdin system.

Authors:  E OSAWA; L H MUSCHEL
Journal:  J Immunol       Date:  1960-02       Impact factor: 5.422

3.  The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena.

Authors:  L PILLEMER; L BLUM; I H LEPOW; O A ROSS; E W TODD; A C WARDLAW
Journal:  Science       Date:  1954-08-20       Impact factor: 47.728

4.  Initiation of the alternative pathway of complement: recognition of activators by bound C3b and assembly of the entire pathway from six isolated proteins.

Authors:  R D Schreiber; M K Pangburn; P H Lesavre; H J Müller-Eberhard
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

5.  Humoral bactericidal systems: nonspecific and specific mechanisms.

Authors:  R C Skarnes
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

6.  The properdin system and immunity. V. The bactericidal activity of the properdin system.

Authors:  A C WARDLAW; L PILLEMER
Journal:  J Exp Med       Date:  1956-05-01       Impact factor: 14.307

7.  Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution.

Authors:  M K Pangburn; R D Schreiber; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1977-07-01       Impact factor: 14.307

8.  Quantitative studies on the properdin-complement system.

Authors:  M A LEON
Journal:  J Exp Med       Date:  1956-03-01       Impact factor: 14.307

9.  Studies on natural antibodies to gram-negative bacteria.

Authors:  J G MICHAEL; J L WHITBY; M LANDY
Journal:  J Exp Med       Date:  1962-01-01       Impact factor: 14.307

10.  Alternative pathway of complement: demonstration and characterization of initiating factor and its properdin-independent function.

Authors:  R D Schreiber; O Götze; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1976-10-01       Impact factor: 14.307

View more
  57 in total

1.  An evaluation of the role of properdin in alternative pathway activation on Neisseria meningitidis and Neisseria gonorrhoeae.

Authors:  Sarika Agarwal; Viviana P Ferreira; Claudio Cortes; Michael K Pangburn; Peter A Rice; Sanjay Ram
Journal:  J Immunol       Date:  2010-06-07       Impact factor: 5.422

2.  Pseudomonas aeruginosa Psl polysaccharide reduces neutrophil phagocytosis and the oxidative response by limiting complement-mediated opsonization.

Authors:  Meenu Mishra; Matthew S Byrd; Susan Sergeant; Abul K Azad; Matthew R Parsek; Linda McPhail; Larry S Schlesinger; Daniel J Wozniak
Journal:  Cell Microbiol       Date:  2011-11-10       Impact factor: 3.715

3.  Anti-mouse properdin TSR 5/6 monoclonal antibodies block complement alternative pathway-dependent pathogenesis.

Authors:  Paula Bertram; Antonina M Akk; Hui-fang Zhou; Lynne M Mitchell; Christine T N Pham; Dennis E Hourcade
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2015-02

4.  Interaction of complement with serum-sensitive and serum-resistant strains of Pseudomonas aeruginosa.

Authors:  N L Schiller; K A Joiner
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

5.  Multimeric complement component C9 is necessary for killing of Escherichia coli J5 by terminal attack complex C5b-9.

Authors:  K A Joiner; M A Schmetz; M E Sanders; T G Murray; C H Hammer; R Dourmashkin; M M Frank
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

6.  Activation of the alternative and classical complement pathways by Entamoeba histolytica.

Authors:  J Calderon; R D Schreiber
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

7.  Sensitivity of Capnocytophaga species to bactericidal properties of human serum.

Authors:  M E Wilson; R Burstein; J T Jonak-Urbanczyk; R J Genco
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

8.  Inhibition of intracellular bacterial replication in fibroblasts is dependent on the perforin-like protein (perforin-2) encoded by macrophage-expressed gene 1.

Authors:  Ryan McCormack; Lesley R de Armas; Motoaki Shiratsuchi; Jahir E Ramos; Eckhard R Podack
Journal:  J Innate Immun       Date:  2012-12-15       Impact factor: 7.349

9.  Serum sensitivity of a Pseudomonas aeruginosa mucoid strain.

Authors:  N L Schiller; M J Alazard; R S Borowski
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

Review 10.  Killing machines: three pore-forming proteins of the immune system.

Authors:  Ryan McCormack; Lesley de Armas; Motoaki Shiratsuchi; Eckhard R Podack
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.